Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Sernova Corp T.SVA

Alternate Symbol(s):  SEOVF

Sernova Corp. is a Canada-based clinical-stage biotechnology company, which is developing therapeutic cell technologies for chronic diseases, including insulin-dependent diabetes, thyroid disease, and blood disorders that include hemophilia A. The Company is focused on developing a functional cure for insulin-dependent diabetes with its therapeutic cell technology, the Cell Pouch System, a novel implantable and scalable medical device with immune protected therapeutic cells. The Cell Pouch is a scalable, implantable medical device. The Cell Pouch is designed to create a vascularized organ-like environment for the transplantation and engraftment of therapeutic cells. Its regenerative medicine therapeutic approach is to provide cell therapies where the cells, transplanted within an organ-like vascularized implantable device, the Cell Pouch, generates proteins, hormones or factors released into the bloodstream for treatment of diseases requiring replacement of these molecules in the body.


TSX:SVA - Post by User

Comment by MustangSalleyon Jun 17, 2021 11:15am
137 Views
Post# 33402039

RE:RE:Questions and... Speculations

RE:RE:Questions and... Speculations

steadfast wrote: MoneyMouth - you are 100% correct.  SVA must abide under strict confidentiality
agreements with Big Pharma colloborations.  If the names of the Pharmas were ever
carelessly mentioned  on a BB, the Big Pharmas would never trust SVA again, SVA
would be toast.  As shareholders we are not privy to this information and must respect
the confidentiality. 

We do know we have the only Clinical Patient in the World who is 14 months+
insulin independent. SVA are way ahead of the competition.  We have a pouch that
does not fibrose.  The size of SEMMA device will cause it to fibrose.  Via-Cyte have
experienced fibrose.

 


Steadfast,

Semma device is a nanofiber  device , there is no need for surgery . It is microscopic from which cells are delivered to the Goldilocks site without immunosuppression. Can you explain how fibrosis would happen with Nice device with the size you are mentioning  ?   Please refrain from using "Fanny " in your response .

Ms Sally 

<< Previous
Bullboard Posts
Next >>